ATE275727T1 - Screening nach modulatoren der funktion von immunstimulatorischer dna - Google Patents
Screening nach modulatoren der funktion von immunstimulatorischer dnaInfo
- Publication number
- ATE275727T1 ATE275727T1 AT00931983T AT00931983T ATE275727T1 AT E275727 T1 ATE275727 T1 AT E275727T1 AT 00931983 T AT00931983 T AT 00931983T AT 00931983 T AT00931983 T AT 00931983T AT E275727 T1 ATE275727 T1 AT E275727T1
- Authority
- AT
- Austria
- Prior art keywords
- immunostimulatory
- binding proteins
- odn
- odns
- proteins
- Prior art date
Links
- 230000003308 immunostimulating effect Effects 0.000 title abstract 15
- 238000012216 screening Methods 0.000 title abstract 2
- 229940046166 oligodeoxynucleotide Drugs 0.000 abstract 8
- 102000052510 DNA-Binding Proteins Human genes 0.000 abstract 4
- 108700020911 DNA-Binding Proteins Proteins 0.000 abstract 3
- 230000001413 cellular effect Effects 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 102000044126 RNA-Binding Proteins Human genes 0.000 abstract 2
- 108700020471 RNA-Binding Proteins Proteins 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 101710096438 DNA-binding protein Proteins 0.000 abstract 1
- 102000017013 Heterogeneous Nuclear Ribonucleoprotein A1 Human genes 0.000 abstract 1
- 108010014594 Heterogeneous Nuclear Ribonucleoprotein A1 Proteins 0.000 abstract 1
- 102000036541 Heterogeneous Nuclear Ribonucleoprotein D0 Human genes 0.000 abstract 1
- 108091021225 Heterogeneous Nuclear Ribonucleoprotein D0 Proteins 0.000 abstract 1
- 102000031528 Heterogeneous-Nuclear Ribonucleoprotein D Human genes 0.000 abstract 1
- 108010085241 Heterogeneous-Nuclear Ribonucleoprotein D Proteins 0.000 abstract 1
- 102000019297 Lupus La proteins Human genes 0.000 abstract 1
- 108050006655 Lupus La proteins Proteins 0.000 abstract 1
- 102100021010 Nucleolin Human genes 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
- -1 competitors Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000007246 mechanism Effects 0.000 abstract 1
- 108010044762 nucleolin Proteins 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13183099P | 1999-04-29 | 1999-04-29 | |
| US18684500P | 2000-03-03 | 2000-03-03 | |
| PCT/US2000/011697 WO2000067023A1 (en) | 1999-04-29 | 2000-04-28 | Screening for immunostimulatory dna functional modifyers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE275727T1 true ATE275727T1 (de) | 2004-09-15 |
Family
ID=26829832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00931983T ATE275727T1 (de) | 1999-04-29 | 2000-04-28 | Screening nach modulatoren der funktion von immunstimulatorischer dna |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1177439B1 (de) |
| AT (1) | ATE275727T1 (de) |
| AU (1) | AU4978100A (de) |
| DE (1) | DE60013591T2 (de) |
| WO (1) | WO2000067023A1 (de) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030026782A1 (en) | 1995-02-07 | 2003-02-06 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US7935675B1 (en) | 1994-07-15 | 2011-05-03 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| EP0855184A1 (de) | 1997-01-23 | 1998-07-29 | Grayson B. Dr. Lipford | Pharmazeutisches Präparat das ein Polynukleotid und ein Antigen enthält, insbesondere zur Impfung |
| US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| SI1077722T1 (sl) | 1998-05-22 | 2007-02-28 | Ottawa Health Research Inst | Metode in produkti za induciranje sluznicne imunosti |
| US6977245B2 (en) | 1999-04-12 | 2005-12-20 | The United States Of America As Represented By The Department Of Health And Human Services | Oligodeoxynucleotide and its use to induce an immune response |
| EP1176966B1 (de) | 1999-04-12 | 2013-04-03 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Oligodeoxynukleotide und deren verwendung zur induktion einer immunreaktion |
| NZ517929A (en) * | 1999-09-25 | 2004-02-27 | Univ Iowa Res Found | Immunostimulatory nucleic acids |
| US6949520B1 (en) | 1999-09-27 | 2005-09-27 | Coley Pharmaceutical Group, Inc. | Methods related to immunostimulatory nucleic acid-induced interferon |
| AU2001227889A1 (en) | 2000-01-14 | 2001-07-24 | The United States of America, represented by The Secretary, Department of Health & Human Services | Oligodeoxynucleotide and its use to induce an immune response |
| US7585847B2 (en) | 2000-02-03 | 2009-09-08 | Coley Pharmaceutical Group, Inc. | Immunostimulatory nucleic acids for the treatment of asthma and allergy |
| US7157437B2 (en) | 2000-03-10 | 2007-01-02 | Dynavax Technologies Corporation | Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences |
| US20020098199A1 (en) | 2000-03-10 | 2002-07-25 | Gary Van Nest | Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences |
| US7129222B2 (en) | 2000-03-10 | 2006-10-31 | Dynavax Technologies Corporation | Immunomodulatory formulations and methods for use thereof |
| US20010046967A1 (en) | 2000-03-10 | 2001-11-29 | Gary Van Nest | Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide |
| US20030129251A1 (en) | 2000-03-10 | 2003-07-10 | Gary Van Nest | Biodegradable immunomodulatory formulations and methods for use thereof |
| AU2001274817A1 (en) | 2000-05-05 | 2001-11-20 | The Regents Of The University Of California | Agents that modulate dna-pk activity and methods of use thereof |
| EP1296714B1 (de) | 2000-06-22 | 2009-08-26 | University Of Iowa Research Foundation | Kombination von CpG und Antikörpern gegen CD19,CD20,CD22 oder CD40 zur Prävention oder Behandlung von Krebs. |
| JP2005500806A (ja) | 2000-09-15 | 2005-01-13 | コーリー ファーマシューティカル ゲーエムベーハー | ＣｐＧに基づく免疫アゴニスト／免疫アンタゴニストの高スループットスクリーニングのためのプロセス |
| KR100881923B1 (ko) | 2000-12-27 | 2009-02-04 | 다이나박스 테크놀로지 코퍼레이션 | 면역자극 폴리뉴클레오티드 및 그것의 사용 방법 |
| EP2423335B1 (de) | 2001-06-21 | 2014-05-14 | Dynavax Technologies Corporation | Chimäre immunmodulierende Verbindungen und Verwendungsverfahren dafür |
| US20030133988A1 (en) | 2001-08-07 | 2003-07-17 | Fearon Karen L. | Immunomodulatory compositions, formulations, and methods for use thereof |
| WO2003020884A2 (en) | 2001-08-14 | 2003-03-13 | The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services | Method for rapid generation of mature dendritic cells |
| ATE411054T1 (de) | 2001-08-17 | 2008-10-15 | Coley Pharm Gmbh | Kombinations-motif-immunstimulierende oligonukleotide mit verbesserter wirkung |
| US8563592B2 (en) | 2001-11-01 | 2013-10-22 | Spectrum Pharmaceuticals, Inc. | Bladder cancer treatment and methods |
| AU2002350115A1 (en) | 2001-11-01 | 2003-05-12 | Spectrum Pharmaceuticals, Inc. | Medical compositions for intravesical treatment of bladder cancer |
| WO2003054161A2 (en) | 2001-12-20 | 2003-07-03 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS |
| EP3006043B1 (de) | 2002-04-04 | 2019-05-29 | Zoetis Belgium S.A. | Immunostimulatorische g,u-haltige oligoribonucleotide |
| JP2005529590A (ja) | 2002-04-17 | 2005-10-06 | ノバルティス アクチエンゲゼルシャフト | ＡＲＥ含有ｍＲＮＡとＨｕＲタンパク質の結合のインヒビターの同定方法 |
| CA2388049A1 (en) | 2002-05-30 | 2003-11-30 | Immunotech S.A. | Immunostimulatory oligonucleotides and uses thereof |
| US20040053880A1 (en) | 2002-07-03 | 2004-03-18 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
| US7576066B2 (en) | 2002-07-03 | 2009-08-18 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
| US7605138B2 (en) | 2002-07-03 | 2009-10-20 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
| US7569553B2 (en) | 2002-07-03 | 2009-08-04 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
| US7807803B2 (en) | 2002-07-03 | 2010-10-05 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
| AR040996A1 (es) | 2002-08-19 | 2005-04-27 | Coley Pharm Group Inc | Acidos nucleicos inmunoestimuladores |
| CN1753687A (zh) | 2002-10-29 | 2006-03-29 | 科勒制药集团股份有限公司 | Cpg寡核苷酸在治疗丙型肝炎病毒感染中的应用 |
| WO2004098491A2 (en) | 2002-11-01 | 2004-11-18 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | METHOD OF PREVENTING INFECTIONS FROM BIOTERRORISM AGENTS WITH IMMUNOSTIMULATORY CpG OLIGONUCLEOTIDES |
| CA2502015A1 (en) | 2002-12-11 | 2004-06-24 | Coley Pharmaceutical Group, Inc. | 5' cpg nucleic acids and methods of use |
| US8158768B2 (en) | 2002-12-23 | 2012-04-17 | Dynavax Technologies Corporation | Immunostimulatory sequence oligonucleotides and methods of using the same |
| JP5102959B2 (ja) | 2002-12-23 | 2012-12-19 | ダイナバックス テクノロジーズ コーポレイション | 免疫刺激配列オリゴヌクレオチド及びその使用方法 |
| EP1631687A2 (de) * | 2003-04-22 | 2006-03-08 | Coley Pharmaceutical GmbH | Verfahren und produkte zur identifizierung und beurteilung von tlr-liganden |
| EP1678303A2 (de) | 2003-10-30 | 2006-07-12 | Coley Pharmaceutical GmbH | C-klasse-oligonukleotidanaloge mit verbesserter immunstimulatorischer potency |
| DE10361502A1 (de) * | 2003-12-23 | 2005-07-28 | Phenion Gmbh & Co. Kg | Kosmetische oder pharmazeutische Zubereitungen enthaltend Superstruktur-bildende Nukleinsäure-Sequenzen |
| MY159370A (en) | 2004-10-20 | 2016-12-30 | Coley Pharm Group Inc | Semi-soft-class immunostimulatory oligonucleotides |
| WO2006056142A1 (en) | 2004-11-29 | 2006-06-01 | Changchun Huapu Biotechnology Co., Ltd. | Cpg single-strand deoxynucleotides for use as adjuvant |
| JP4538522B2 (ja) | 2005-11-25 | 2010-09-08 | コーリー ファーマシューティカル ゲーエムベーハー | 免疫刺激性オリゴリボヌクレオチド |
| PT2078080E (pt) | 2006-09-27 | 2015-09-18 | Coley Pharm Gmbh | Análogos dos oligonucleotídeos cpg que contêm análogos t hidrofóbicos com atividade imunoestimulante potenciada |
| ES2569907T3 (es) | 2008-06-27 | 2016-05-13 | Zoetis Services Llc | Composiciones adyuvantes novedosas |
| UA130246C2 (uk) | 2013-09-19 | 2025-12-31 | Зоетіс Сервісіз Ллс | Ад'ювант на основі олії |
| CN115317600A (zh) | 2015-01-16 | 2022-11-11 | 硕腾服务有限责任公司 | 口蹄疫疫苗 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1167379A3 (de) * | 1994-07-15 | 2004-09-08 | University Of Iowa Research Foundation | Immunomodulatorische Oligonukleotide |
| DK1005368T3 (da) * | 1997-03-10 | 2010-01-04 | Ottawa Hospital Res Inst | Anvendelse af nukleinsyrer, der indeholder ikke-metyleret CpG dinukleotid i kombination med alun som hjælpestoffer |
-
2000
- 2000-04-28 EP EP00931983A patent/EP1177439B1/de not_active Expired - Lifetime
- 2000-04-28 WO PCT/US2000/011697 patent/WO2000067023A1/en not_active Ceased
- 2000-04-28 AT AT00931983T patent/ATE275727T1/de not_active IP Right Cessation
- 2000-04-28 AU AU49781/00A patent/AU4978100A/en not_active Abandoned
- 2000-04-28 DE DE60013591T patent/DE60013591T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE60013591D1 (de) | 2004-10-14 |
| EP1177439A1 (de) | 2002-02-06 |
| AU4978100A (en) | 2000-11-17 |
| EP1177439B1 (de) | 2004-09-08 |
| DE60013591T2 (de) | 2005-02-03 |
| WO2000067023A1 (en) | 2000-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60013591D1 (de) | Screening nach modulatoren der funktion von immunstimulatorischer dna | |
| KR0133131B1 (en) | Peptide nucleic acids | |
| CA2256545A1 (en) | Probe for analysis of nucleic acids | |
| Vollmer et al. | Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes | |
| Brown et al. | Direct recognition of mRNA stop signals by Escherichia coli polypeptide chain release factor two | |
| EP1975172A3 (de) | Hochaffine TGFß-Nukleinsäureliganden und -inhibitoren | |
| ES2122692T3 (es) | Procedimiento de amplificacion de acidos nucleicos en fase solida y equipo de reactivos para su realizacion. | |
| CY1105958T1 (el) | Πολυαμιδικα παραγωγα νουκλεϊκου οξεως, μεσα και μεθοδοι παρασκευης τους | |
| Vollmer et al. | Modulation of CpG oligodeoxynucleotide-mediated immune stimulation by locked nucleic acid (LNA) | |
| DE69734783D1 (de) | Peptidnukleinsäuren mit erhöhter bindungsaffinität, sequenzspezifität und löslichkeit | |
| WO1998026093A3 (en) | Fluorescent nucleotide analog hairpin formation for detection of nucleic acid hybridization | |
| DE60143314D1 (de) | Estimmung der präsenz von cryptosporidium organismen in einer testprobe | |
| DE69815370D1 (de) | Fluoreszend-konjugaten von nukleosiden und von nukleotiden, ihrer verfahren zur herstellung und ihrer verwendungen | |
| DE68926455D1 (de) | Verfahren zur identifizierung von bakterien | |
| Lang et al. | Guanosine‐rich oligodeoxynucleotides induce proliferation of macrophage progenitors in cultures of murine bone marrow cells | |
| Chu et al. | Crosslinking transcription factors to their recognition sequences with PtII complexes | |
| WO1996029407A3 (en) | Cellubrevin homologs | |
| DE60208946D1 (de) | Reaktiver Träger zur Bestimmung von DNA Fragmenten | |
| Krieg | Immune stimulation by oligonucleotides | |
| SE9902565D0 (sv) | Probe for analysis of nucleic acids | |
| WO2001096593A3 (en) | Novel motor proteins and methods for their use | |
| EA200100987A1 (ru) | Реагенты, содержащие бороновые кислоты, и олигонуклеотиды | |
| WO2001040510A3 (de) | Dynamische sequenzierung durch hybridisierung | |
| WO2000056923A3 (en) | Genetic analysis | |
| Palindromes | B. Sequence-Specific Immune Effects of CpG Motifs in Oligodeoxynucleotides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |